For a supposedly greedy, all-powerful, price-hiking Big Pharma megacap, Pfizer's (PFE) stock sure isn't doing too well over the long term. There seems to be this persistent belief that because Pfizer is one of the biggest names in pharmaceuticals, it can institute price hikes on a whim with no consequences, just for the sake of making more money because it feels like it. This is essentially what President Trump tweeted out earlier this week when he publicly protested Pfizer's plans to hike prices for 91 of its drugs.
Meanwhile, Pfizer's share price hit its all-time highs of $48 way back 18 years ago and hasn't even gotten close to regaining them. Is it really all that powerful?
